UNSPSC 51283901: Sulfacetamide

This classification denotes a sulfonamide anti-infective agent with the molecular formula C8H10N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4965G3J0F5, chemically known as sulfanilamide, n(sup 1)-acetyl- but generally known as sulfacetamide, which bears US NIH Compound Identifier 5320. European Medicines Agency schedules Sulfacetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10687MIG.

UNSPSC 51283901 Sulfacetamide (Commodity) does not align with recent state and local procurement activity sourced under this code. The two most recent opportunities posted under the code involve naloxone and safe drug deactivation systems (Seminole County, Florida, IFB, July 2026) and doxycycline hyclate and ciprofloxacin hydrochloride tablets awarded to Chartwell Rx LLC through the Illinois Department of Public Health's MMCAP Infuse consortium (August 2026). Neither represents sulfacetamide procurement, indicating either systematic code misclassification by issuing bodies or minimal recent demand for this specific pharmaceutical ingredient under state and local contracts.

The narrow activity on record reflects solicitation from a county health department and a state health agency operating through a cooperative purchasing vehicle, suggesting that when sulfacetamide or related pharmaceutical products do move through state and local procurement, they flow through established pharmacy aggregation frameworks rather than standalone buys. The geographic footprint captured here spans Florida and Illinois; no additional states or regions show relevant recent activity in the source. Given the mismatch between the code's nominal scope and the pharmaceutical categories actually appearing in recent postings, vendors should verify code alignment at pre-bid or inquiry stage rather than assume standing demand under this Commodity classification.